Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro's UK private price changed significantly from 1 September 2025, when Eli Lilly raised its list price across the range — the highest-dose pen rose from around £122 to around £330. Private providers set their own fees on top of that, so what you'll pay today depends heavily on your dose and who supplies it. Mounjaro is a prescription-only medicine: a prescriber must assess your suitability before any supply is legal, and that clinical step should always be reflected in what you pay. At nume, one transparent price covers your consultation, prescription, treatment, and free next-working-day delivery — with no subscription and no hidden additions.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly supplies Mounjaro to UK pharmacies at a set wholesale price. From 1 September 2025 that price increased sharply. You can read a full breakdown of how the Eli Lilly Mounjaro UK price hike unfolded, including the figures widely covered in pharmacy trade press and confirmed by Lilly UK, which show the 15mg pen moving from roughly £122 to roughly £330 at list level. Lower doses saw smaller but still meaningful increases. These are not retail prices; they are the cost at which the supply chain sells to a pharmacy, before the pharmacy adds its own dispensing costs, clinical infrastructure, and margin.
What this means in practice: private monthly prices across the UK market have typically ranged from around £149 to £375 depending on dose and provider since September 2025. Those figures are hedged deliberately, individual providers set their own rates and they do change. If you want detail on how the increase broke down across the dose range, the full picture of the Lilly UK price increase is worth reading before you compare quotes.
The key point is that the list price sets a floor. Any legitimate private provider has to cover it, along with the real costs of running a GPhC-registered pharmacy, employing prescribers, and delivering safely. A quote that sits far below the market range should raise a question, not a cheer.
A monthly price quoted on a website may cover the pen itself and nothing else. Before comparing numbers, it is worth spending sixty seconds checking whether the figure includes a prescriber consultation, or whether that is billed separately at the start and on every repeat. Delivery charges vary: some providers add £5–£15 per order. Some charge an upfront registration or onboarding fee. Aftercare (access to a clinician when you have questions mid-cycle) is often listed as a paid add-on or simply absent.
Dose reviews matter too. If you want to understand the treatment in full before looking at costs, our Mounjaro information page explains how tirzepatide works and what the titration process involves, because Mounjaro is titrated upward as your prescriber decides you are ready, and if each dose change triggers a separate consultation charge, the cumulative cost can be considerably higher than the headline figure suggested. The broader breakdown of what private Mounjaro costs covers these line items in more detail, and the 5mg price specifically illustrates how costs shift as the dose changes.
None of this is a reason to distrust any particular provider. It is simply a prompt to read the small print. For a prescription medicine that requires ongoing clinical oversight, the total cost of safe supply is the number that matters.
We are deliberately not the lowest-priced option in this market. That is a choice, not an oversight. The current treatment pricing is shown on our weight-loss treatments page, and it covers everything: free consultation, prescription, treatment, and free next-working-day DPD delivery, every time. No subscription locks you in. No auto-renewal charges your card. Every repeat order goes through a fresh clinical review by one of our GPhC-registered prescribers before anything is dispensed.
Our pharmacy's GPhC registration is public and verifiable in seconds at the GPhC register (9012878). For a transparent look at what Eli Lilly Mounjaro prices mean for what you pay, including how wholesale costs feed through to retail quotes, that page sets out the detail clearly. What we offer is not the fastest race to the cheapest price, it is a clinically sound, fully transparent service built around your safety. Some people will choose a lower quote. We think others will find that what is included here is worth the difference.
Mounjaro is a Prescription-Only Medicine. The MHRA has issued clear public warnings about fake weight-loss pens seized from unverified sellers, some containing insulin rather than tirzepatide, leading to hospitalisations. In October 2025, enforcement teams raided an illicit UK manufacturing site producing counterfeit tirzepatide pens. The pattern is consistent: low prices and unverifiable sellers go together.
For any medication requiring a prescription, the supply chain matters as much as the molecule. Genuine Mounjaro, dispensed following a real prescriber assessment through a registered pharmacy, is what clinical trials tested and what the NICE appraisal of tirzepatide (TA1026) is built around. A lower number on a website is not a saving if the product is not what it claims to be. If you have questions about what legitimate pricing looks like, our FAQs cover the most common ones, and our team is available through the contact page if you want to speak to someone directly. Speak to our prescribers by starting a free consultation, the process takes a few minutes and there is no charge to find out if you are clinically suitable.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.